AAAAAA
Results: 76-100/1748
Authors:
Taniyama, Y
Ito, H
Morishita, R
Ogihara, T
Citation: Y. Taniyama et al., Potential of microvascular reperfusion with adjunctive pharmacological intervention - Its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction, DRUGS, 61(4), 2001, pp. 437-441
Authors:
Zhanel, GG
Dueck, M
Hoban, DJ
Vercaigne, LM
Embil, JM
Gin, AS
Karlowsky, JA
Citation: Gg. Zhanel et al., Review of macrolides and ketolides - Focus on respiratory tract infections, DRUGS, 61(4), 2001, pp. 443-498
Authors:
Clemett, D
Goa, KL
Citation: D. Clemett et Kl. Goa, Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis andacute pain (vol 59, pg 967, 2000), DRUGS, 61(4), 2001, pp. 498-498
Authors:
Mantovani, G
Maccio, A
Massa, E
Madeddu, C
Citation: G. Mantovani et al., Managing cancer-related anorexia/cachexia, DRUGS, 61(4), 2001, pp. 499-514
Authors:
McKeage, K
Plosker, GL
Citation: K. Mckeage et Gl. Plosker, Argatroban, DRUGS, 61(4), 2001, pp. 515-522
Authors:
Warkentin, TE
Citation: Te. Warkentin, Argatroban - A viewpoint, DRUGS, 61(4), 2001, pp. 523-523
Authors:
Walenga, JM
Citation: Jm. Walenga, Argatroban - A viewpoint, DRUGS, 61(4), 2001, pp. 523-524
Authors:
Perry, CM
Jarvis, B
Citation: Cm. Perry et B. Jarvis, Linezolid - A review of its use in the management of serious Gram-positiveinfections, DRUGS, 61(4), 2001, pp. 525-551
Authors:
De Ponti, F
Tonini, M
Citation: F. De Ponti et M. Tonini, Irritable bowel syndrome - New agents targeting serotonin receptor subtypes, DRUGS, 61(3), 2001, pp. 317-332
Authors:
Mather, LE
Chang, DHT
Citation: Le. Mather et Dht. Chang, Cardiotoxicity with modern local anaesthetics - Is there a safer choice?, DRUGS, 61(3), 2001, pp. 333-342
Authors:
Toivanen, A
Citation: A. Toivanen, Bacteria-triggered reactive arthritis - Implications for antibacterial treatment, DRUGS, 61(3), 2001, pp. 343-351
Authors:
Guay, DR
Citation: Dr. Guay, An update on the role of nitrofurans in the management of urinary tract infections, DRUGS, 61(3), 2001, pp. 353-364
Authors:
Yang, X
Citation: X. Yang, Does allergen immunotherapy alter the natural course of allergic disorders?, DRUGS, 61(3), 2001, pp. 365-374
Authors:
Karmazyn, M
Sostaric, JV
Gan, XT
Citation: M. Karmazyn et al., The myocardial Na+/H+ exchanger - A potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation ofpostinfarction heart failure, DRUGS, 61(3), 2001, pp. 375-389
Authors:
Holimon, TD
Chafin, CC
Self, TH
Citation: Td. Holimon et al., Nocturnal asthma uncontrolled by inhaled corticosteroids - Theophylline orlong-acting beta(2) agonists?, DRUGS, 61(3), 2001, pp. 391-418
Authors:
Leighton, C
Citation: C. Leighton, Drug treatment of scleroderma, DRUGS, 61(3), 2001, pp. 419-427
Authors:
Amsden, GW
Duran, JM
Citation: Gw. Amsden et Jm. Duran, Interpretation of antibacterial susceptibility reports - In vitro versus clinical break-points, DRUGS, 61(2), 2001, pp. 163-166
Authors:
Marchese, A
Schito, GC
Citation: A. Marchese et Gc. Schito, Role of global surveillance in combating bacterial resistance, DRUGS, 61(2), 2001, pp. 167-173
Authors:
Robert, PY
Adenis, JP
Citation: Py. Robert et Jp. Adenis, Comparative review of topical ophthalmic antibacterial preparations, DRUGS, 61(2), 2001, pp. 175-185
Authors:
Ljungman, P
Citation: P. Ljungman, Prophylaxis against herpesvirus infections in transplant recipients, DRUGS, 61(2), 2001, pp. 187-196
Authors:
Fariello, RG
Citation: Rg. Fariello, Pharmacodynamic and pharmacokinetic features of cabergoline: rationale foruse in Parkinson's disease. (vol 55, pg 10, 1998), DRUGS, 61(2), 2001, pp. 196-196
Authors:
Davidson, MH
Citation: Mh. Davidson, Safety profiles for the HMG-CoA reductase inhibitors - Treatment and trust, DRUGS, 61(2), 2001, pp. 197-206
Authors:
Walsh, GM
Annunziato, L
Frossard, N
Knol, K
Levander, S
Nicolas, JM
Taglialatela, M
Tharp, MD
Tillement, JP
Timmerman, H
Citation: Gm. Walsh et al., New insights into the second generation antihistamines, DRUGS, 61(2), 2001, pp. 207-236
Authors:
Grunstein, RR
Hedner, J
Grote, L
Citation: Rr. Grunstein et al., Treatment options for sleep apnoea, DRUGS, 61(2), 2001, pp. 237-251
Authors:
Easthope, S
Jarvis, B
Citation: S. Easthope et B. Jarvis, Omalizumab, DRUGS, 61(2), 2001, pp. 253-260